CANY
ADMA icon

Caxton Associates (New York)’s ADMA Biologics ADMA Stock Holding History

Caxton Associates (New York)’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$884K Sell
51,568
-24,280
-32% -$457K 0.03% 238
2024
Q3 		$1.52M Sell
75,848
-130,879
-63% -$2.04M 0.07% 175
2024
Q2 		$2.31M Sell
206,727
-182,464
-47% -$1.53M 0.09% 135
2024
Q1 		$2.57M Buy
389,191
+369,498
+1,876% +$2.02M 0.17% 98
2023
Q4 		$89K Buy
+19,693
New +$72.9K ﹤0.01% 447
2023
Q3 		– Sell
-140,190
Closed -$517K – 391
2023
Q2 		$517K Sell
140,190
-64,729
-32% -$240K 0.08% 264
2023
Q1 		$678K Sell
204,919
-30,256
-13% -$105K 0.11% 211
2022
Q4 		$912K Buy
+235,175
New +$725K 0.07% 126

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return